Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study

Archives of Cardiovascular Diseases

Volumn 107, Issue 2, 2014, Pages 112-121

  Donal, Erwan ^a,b,i   Lund, Lars H ^c,i   Oger, Emmanuel ^d,i   Hage, Camilla ^c,i   Persson, Hans ^e,i   Reynaud, Amélie ^b,i   Ennezat, Pierre Vladimir ^f,i   Bauer, Fabrice ^g,i   Sportouch Dukhan, Catherine ^h,i   Drouet, Élodie ^h,i   Daubert, Jean Claude ^a,b,i   Linde, Cecilia ^c,i  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e DANDERYD HOSPITAL   (Sweden)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g ROUEN UNIVERSITY HOSPITAL   (France)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁱ Societe Francaise de Cardiologie   (France)

Author keywords

Clinical characteristics; Echocardiographic characteristics; Heart failure with preserved ejection fraction; Registry

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; LOOP DIURETIC AGENT;

ACUTE HEART FAILURE; AGED; ANEMIA; ARTICLE; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; TACHYCARDIA;

CARACTÉRISTIQUES CLINIQUES; CLINICAL CHARACTERISTICS; ECHOCARDIOGRAPHIC CHARACTERISTICS; ÉCHOCARDIOGRAPHIE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; INSUFFISANCE CARDIAQUE À FRACTION D'ÉJECTION PRÉSERVÉE; REGISTRE; REGISTRY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COMORBIDITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FRANCE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SEX FACTORS; STROKE VOLUME; SWEDEN; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84896130766     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2013.11.002     Document Type: Article

References (32)

1. D.W. Kitzman, W.C. Little, and P.H. Brubaker et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure JAMA 288 2002 2144 2150
2. R.S. Vasan, M.G. Larson, E.J. Benjamin, J.C. Evans, C.K. Reiss, and D. Levy Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort J Am Coll Cardiol 33 1999 1948 1955
3. R.S. Bhatia, J.V. Tu, and D.S. Lee et al. Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
4. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
5. C.S. Lam, E. Donal, E. Kraigher-Krainer, and R.S. Vasan Epidemiology and clinical course of heart failure with preserved ejection fraction Eur J Heart Fail 13 2011 18 28
6. C.M. O'Connor, W.T. Abraham, and N.M. Albert et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Am Heart J 156 2008 662 673
7. C. Tribouilloy, D. Rusinaru, and H. Mahjoub et al. Prognosis of heart failure with preserved ejection fraction: a 5-year prospective population-based study Eur Heart J 29 2008 339 347
8. M. Senni, C.M. Tribouilloy, and R.J. Rodeheffer et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991 Circulation 98 1998 2282 2289
9. W.J. Paulus, C. Tschope, and J.E. Sanderson et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2007 2539 2550
10. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
11. C.W. Yancy, M. Jessup, and B. Bozkurt et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 128 2013 e240 e319
12. I. Graham, D. Atar, and K. Borch-Johnsen et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts), Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology Eur J Cardiovasc Prev Rehabil 14 Suppl. 2 2007 S1 S113
13. L.H. Lund, J. Jurga, and M. Edner et al. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction Eur Heart J 34 2013 529 539
14. H. Persson, E. Lonn, and M. Edner et al. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES J Am Coll Cardiol 49 2007 687 694
15. N.M. Hawkins, D. Wang, and J.J. McMurray et al. Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme Eur J Heart Fail 9 2007 510 517
16. J.J. McMurray, P.E. Carson, and M. Komajda et al. Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial Eur J Heart Fail 10 2008 149 156
17. J.C. Eicher, G. Laurent, and A. Mathe et al. Atrial dyssynchrony syndrome: an overlooked phenomenon and a potential cause of " diastolic" heart failure Eur J Heart Fail 14 2012 248 258
18. A.P. Lee, Q. Zhang, and G. Yip et al. LV mechanical dyssynchrony in heart failure with preserved ejection fraction complicating acute coronary syndrome JACC Cardiovasc Imaging 4 2011 348 357
19. E. Donal, L.H. Lund, and C. Linde et al. Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction Eur J Heart Fail 11 2009 198 204
20. R.M. Lang, L.P. Badano, and W. Tsang et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography Eur Heart J Cardiovasc Imaging 13 2012 1 46
21. G.C. Fonarow, W.T. Abraham, and N.M. Albert et al. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Arch Intern Med 167 2007 1493 1502
22. M. Komajda, O. Hanon, and M. Hochadel et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II Eur Heart J 30 2009 478 486
23. R. West, L. Liang, and G.C. Fonarow et al. Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry Eur J Heart Fail 13 2011 945 952
24. S.D. Solomon, D. Wang, and P. Finn et al. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program Circulation 110 2004 2180 2183
25. M. Komajda, O. Hanon, and M. Hochadel et al. Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I Eur Heart J 28 2007 1310 1318
26. M. Gheorghiade, W.T. Abraham, and N.M. Albert et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226
27. B.M. Massie, P.E. Carson, and J.J. McMurray et al. Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
28. R.T. Campbell, P.S. Jhund, D. Castagno, N.M. Hawkins, M.C. Petrie, and J.J. McMurray What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? J Am Coll Cardiol 60 2012 2349 2356
29. M.R. Zile, J.S. Gottdiener, and S.J. Hetzel et al. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction Circulation 124 2011 2491 2501
30. D.A. Morris, M. Gailani, and A. Vaz Perez et al. Right ventricular myocardial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction J Am Soc Echocardiogr 24 2011 886 897
31. K.H. Haugaa, M.K. Smedsrud, and T. Steen et al. Mechanical dispersion assessed by myocardial strain in patients after myocardial infarction for risk prediction of ventricular arrhythmia JACC Cardiovasc Imaging 3 2010 247 256
32. T.T. Phan, K. Abozguia, and G.N. Shivu et al. Myocardial contractile inefficiency and dyssynchrony in heart failure with preserved ejection fraction and narrow QRS complex J Am Soc Echocardiogr 23 2010 201 206